Posted 9/12/2019 8:28 AM (GMT -5)
Has anyone come across this new treatment that they have used in Europe called Theranostics using gallium-68 (68Ga)-PSMA positron emission tomography/computed tomography (PET/CT)—the diagnostic partner of 177Lu-PSMA radioligand therapy (PRLT); the two form a theranostic nuclear medicine pairing. Theranostics refers to the combination of a predictive biomarker, in this case PSMA, identified through diagnostic imaging using radiolabeled ligands (which lock onto the specific cancer cell receptor/biomarker), with precise therapy targeted on the now-identified cancer cells. The cancer cells are destroyed, while healthy cells are unharmed.
My husband just underwent a PET scan when PSA rose to 0.72 showing 4 spots one of which was not localized. We are also weighing options on next steps.
I have been reading about the Theranostic approach for recurrent prostate cancer patients would love some feedback if anyone else has heard of this treatment that some mention should be the 3 line of care.
They have used this in Germany and Australia but I am not sure if it is approved anywhere globally.
Here is the link to the research being done.
https://www.ncbi.nlm.nih.gov/pmc/articles/pmc5787224/
http://www.psmainfo.org/news